c-Rel antibody (AA 501-505)
Quick Overview for c-Rel antibody (AA 501-505) (ABIN362519)
Target
See all c-Rel AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 501-505
-
Specificity
- The antibody detects endogenous level of total Rel protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
-
Immunogen
- Peptide sequence around AA 501-505 (T-S-S-D-S) derived from Human Rel. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Immunofluorescence: 1:100-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- c-Rel (REL proto-oncogene (c-Rel))
-
Alternative Name
- Rel
-
Background
- The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the 'Rel domain,' which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor (MIM 164008) (Belguise and Sonenshein, 2007 (PubMed18037997)).
-
Molecular Weight
- 78 kDa
-
NCBI Accession
- NP_002899
-
UniProt
- Q04864
Target
-